Effect of Vitamin D Supplementation on Muscular Strength, Musculoskeletal Pain and Headache
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01263288|
Recruitment Status : Completed
First Posted : December 20, 2010
Last Update Posted : June 24, 2013
The primary aim of the present trial is to study the effect of daily vitamin D supplementation on muscular power and force among non-western immigrants living in Oslo, Norway, and secondarily to study the effect of musculoskeletal pain and headache.
The investigators have also prespecified a number of additional research questions about anemia, metabolism and bone turnover, inflammation, diabetes, lipids, itching and kidney function, which because of multiple comparisons should be interpreted with caution unless the statistical evidence for an effect is very strong.
|Condition or disease||Intervention/treatment||Phase|
|Vitamin Deficiency||Dietary Supplement: cholecalciferol Dietary Supplement: Placebo||Phase 4|
Vitamin D deficiency is a widespread public health problem among immigrants from non-Western countries in Norway. As a background for preventive strategies it is important to have best possible knowledge about health consequences of poor vitamin D status, and in this respect much is lacking.
The investigators will aim to study the effect of vitamin D supplementation on muscular strength , musculoskeletal pain and headache among non-western immigrants in Norway with background from Middle East, Africa and South Asia. In addition the intervention gives us the opportunity to study the effect of vitamin D on indicators of other important health issues including anemia, diabetes , lipids, inflammation, metabolism and bone health. The study will also contribute with insight on how to achieve a high compliance. This is of interest in a broader context as poor compliance has been experienced as a problem in primary health care among immigrants with poor vitamin D status.
The study is a randomized, double blinded, placebo-controlled trial which compares two doses of vitamin D supplements, 400 IU and 1000 IU, with placebo and the tablets will be taken daily in a period of 4 months. Three muscle strength tests will be used, and they will be performed before and after the intervention: Counter movement jumps, Chair rising and Handgrip. Level and location of musculoskeletal pain and headache will be recorded at baseline and at end of the study.
A blood sample will be collected from the study subjects at baseline and after 4 months. The level of vitamin D and markers of anemia, metabolism and bone turnover, inflammation, diabetes, lipids and kidney function will be measured.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||251 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||Effect of Vitamin D Supplementation on Muscular Strength, Musculoskeletal Pain and Headache in Immigrants Living in Norway. Randomized, Double Blinded, Placebo Controlled Study|
|Study Start Date :||January 2011|
|Actual Primary Completion Date :||April 2012|
|Actual Study Completion Date :||January 2013|
|Active Comparator: Vitamin D3 (cholecalciferol) 400 IU||
Dietary Supplement: cholecalciferol
Vitamin D3 tablet 400 IU. Once daily by mouth for 4 months
Other Name: NN007
|Active Comparator: Vitamin D3 (cholecalciferol) 1000 IU||
Dietary Supplement: cholecalciferol
Vitamin D3 tablet 1000 IU. Once daily by mouth for 4 months
Other Name: NN008
|Placebo Comparator: Placebo||
Dietary Supplement: Placebo
Microcrystalline cellulose tablet p.o.daily. (Same color, shape and size as vitamin D tablet)
Other Name: NN009
- Muscular strength: jump height [ Time Frame: 4 months ]
- Musculoskeletal pain, headache, muscular strength; chair rising and handgrip [ Time Frame: 4 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01263288
|University of Oslo, Institute of Health and Society|
|Oslo, Norway, 0318|
|Study Chair:||Per Lagerlov, MD, PhD||University of Oslo|
|Study Chair:||Haakon E Meyer, Professor||University of Oslo|